Carcinoma of Unknown Primary Clinical Trials

31 clinical trials for Carcinoma of Unknown Primary across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer — RECRUITING
• Cancer Genetic Testing in Ethnic Populations — RECRUITING · NA
• Genomic Investigation of Unusual Responders — RECRUITING
• Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction — ACTIVE_NOT_RECRUITING · PHASE1
• Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic — ACTIVE_NOT_RECRUITING · PHASE2
• Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP) — COMPLETED · PHASE2
• Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) — COMPLETED
• [18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary origin — TERMINATED · PHASE3
• Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs — WITHDRAWN
• Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS — COMPLETED · PHASE3
• Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary — COMPLETED · PHASE2
• Elective Mucosal Irradiation in Head-and-Neck Cancer of Unknown Primary — OTHER · PHASE2
• Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor — COMPLETED · PHASE3
• PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy — COMPLETED
• Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin — COMPLETED · PHASE2
• Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary — COMPLETED · PHASE2
• High-dose ICE With Amifostine — COMPLETED · PHASE2
• Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer — COMPLETED · PHASE1
• Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary — OTHER · PHASE2
• Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary — COMPLETED · PHASE2
• Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin — WITHDRAWN · PHASE2
• Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin — OTHER · PHASE3
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin — OTHER · PHASE3
• Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer — COMPLETED · PHASE3
• Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors — COMPLETED · PHASE2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. — COMPLETED · PHASE2
• Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors — TERMINATED · PHASE1
• SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck — COMPLETED · PHASE2
• Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site — TERMINATED · PHASE2

Refine this search